Senolytics: A Translational Bridge Between Cellular Senescence and Organismal Aging

Overview

Journal Front Cell Dev Biol

Specialty Cell Biology

Date 2020 Feb 11

PMID 32039197

Citations 27

Authors

Harikrishnan Thoppil

Karl Riabowol

Affiliations

Soon will be listed here.

Abstract

Aging is defined as a progressive decrease in physiological function accompanied by a steady increase in mortality. The antagonistic pleiotropy theory proposes that aging is largely due to the natural selection of genes and pathways that increase fitness and decrease mortality early in life but contribute to deleterious effects and pathologies later in life. Cellular senescence is one such mechanism, which results in a permanent cell cycle arrest that has been described as a mechanism to limit cancer cell growth. However, recent studies have also suggested a dark side of senescence in which a build-up of senescent cells with age leads to increased inflammation due to a senescence-associated secretory phenotype (SASP). This phenotype that includes many cytokines promotes tumorigenesis and can exhaust the pool of immune cells in the body. Studies clearing senescent cells from mice using the p16-based transgene INK-ATTAC have shown that senescent cells can impact both organismal aging and lifespan. Here we discuss these advances that have resulted in the development of a whole new class of compounds known as senolytics, some of which are currently undergoing clinical trials in humans for treating a variety of age-related pathologies such as osteoarthritis.

Citing Articles

The Role of Senescence in Experimental Periodontitis at the Causal Level: An in Vivo Study.

Chu X, Elashiry M, Carroll A, Cornelius Timothius C, Cutler C, Elsayed R Cells. 2025; 14(3).

PMID: 39937017 PMC: 11817363. DOI: 10.3390/cells14030226.

The Role of Molecular and Cellular Aging Pathways on Age-Related Hearing Loss.

Ege T, Tao L, North B Int J Mol Sci. 2024; 25(17).

PMID: 39273652 PMC: 11396656. DOI: 10.3390/ijms25179705.

Gene Therapy Strategies Targeting Aging-Related Diseases.

Yu J, Li T, Zhu J Aging Dis. 2023; 14(2):398-417.

PMID: 37008065 PMC: 10017145. DOI: 10.14336/AD.2022.00725.

The Effects of Nutrient Signaling Regulators in Combination with Phytocannabinoids on the Senescence-Associated Phenotype in Human Dermal Fibroblasts.

Gerasymchuk M, Robinson G, Kovalchuk O, Kovalchuk I Int J Mol Sci. 2022; 23(15).

PMID: 35955938 PMC: 9368899. DOI: 10.3390/ijms23158804.

CD26 is a senescence marker associated with reduced immunopotency of human adipose tissue-derived multipotent mesenchymal stromal cells.

Psaroudis R, Singh U, Lora M, Jeon P, Boursiquot A, Stochaj U Stem Cell Res Ther. 2022; 13(1):358.

PMID: 35883188 PMC: 9327293. DOI: 10.1186/s13287-022-03026-4.

References

Alcorta D, Xiong Y, Phelps D, Hannon G, Beach D, Barrett J . Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts. Proc Natl Acad Sci U S A. 1996; 93(24):13742-7. PMC: 19411. DOI: 10.1073/pnas.93.24.13742. View

Parrinello S, Samper E, Krtolica A, Goldstein J, Melov S, Campisi J . Oxygen sensitivity severely limits the replicative lifespan of murine fibroblasts. Nat Cell Biol. 2003; 5(8):741-7. PMC: 4940195. DOI: 10.1038/ncb1024. View

Gorgoulis V, Adams P, Alimonti A, Bennett D, Bischof O, Bishop C . Cellular Senescence: Defining a Path Forward. Cell. 2019; 179(4):813-827. DOI: 10.1016/j.cell.2019.10.005. View

Baker D, Wijshake T, Tchkonia T, LeBrasseur N, Childs B, van de Sluis B . Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature. 2011; 479(7372):232-6. PMC: 3468323. DOI: 10.1038/nature10600. View

Fuhrmann-Stroissnigg H, Ling Y, Zhao J, McGowan S, Zhu Y, Brooks R . Identification of HSP90 inhibitors as a novel class of senolytics. Nat Commun. 2017; 8(1):422. PMC: 5583353. DOI: 10.1038/s41467-017-00314-z. View

Calimport S, Bentley B, Stewart C, Pawelec G, Scuteri A, Vinciguerra M . To help aging populations, classify organismal senescence. Science. 2019; 366(6465):576-578. PMC: 7193988. DOI: 10.1126/science.aay7319. View

Kenyon C . The first long-lived mutants: discovery of the insulin/IGF-1 pathway for ageing. Philos Trans R Soc Lond B Biol Sci. 2010; 366(1561):9-16. PMC: 3001308. DOI: 10.1098/rstb.2010.0276. View

Justice J, Nambiar A, Tchkonia T, LeBrasseur N, Pascual R, Hashmi S . Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study. EBioMedicine. 2019; 40:554-563. PMC: 6412088. DOI: 10.1016/j.ebiom.2018.12.052. View

Coppe J, Patil C, Rodier F, Sun Y, Munoz D, Goldstein J . Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol. 2008; 6(12):2853-68. PMC: 2592359. DOI: 10.1371/journal.pbio.0060301. View

10.

Barardo D, Thornton D, Thoppil H, Walsh M, Sharifi S, Ferreira S . The DrugAge database of aging-related drugs. Aging Cell. 2017; 16(3):594-597. PMC: 5418190. DOI: 10.1111/acel.12585. View

11.

Brown J, Wei W, Sedivy J . Bypass of senescence after disruption of p21CIP1/WAF1 gene in normal diploid human fibroblasts. Science. 1997; 277(5327):831-4. DOI: 10.1126/science.277.5327.831. View

12.

Rajarajacholan U, Thalappilly S, Riabowol K . The ING1a tumor suppressor regulates endocytosis to induce cellular senescence via the Rb-E2F pathway. PLoS Biol. 2013; 11(3):e1001502. PMC: 3589274. DOI: 10.1371/journal.pbio.1001502. View

13.

Karkoulis P, Stravopodis D, Konstantakou E, Voutsinas G . Targeted inhibition of heat shock protein 90 disrupts multiple oncogenic signaling pathways, thus inducing cell cycle arrest and programmed cell death in human urinary bladder cancer cell lines. Cancer Cell Int. 2013; 13(1):11. PMC: 3583703. DOI: 10.1186/1475-2867-13-11. View

14.

Schopf F, Biebl M, Buchner J . The HSP90 chaperone machinery. Nat Rev Mol Cell Biol. 2017; 18(6):345-360. DOI: 10.1038/nrm.2017.20. View

15.

Gewirtz D, Holt S, Elmore L . Accelerated senescence: an emerging role in tumor cell response to chemotherapy and radiation. Biochem Pharmacol. 2008; 76(8):947-57. DOI: 10.1016/j.bcp.2008.06.024. View

16.

Lundblad V, Szostak J . A mutant with a defect in telomere elongation leads to senescence in yeast. Cell. 1989; 57(4):633-43. DOI: 10.1016/0092-8674(89)90132-3. View

17.

Jeon O, Kim C, Laberge R, Demaria M, Rathod S, Vasserot A . Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment. Nat Med. 2017; 23(6):775-781. PMC: 5785239. DOI: 10.1038/nm.4324. View

18.

Hickson L, Langhi Prata L, Bobart S, Evans T, Giorgadze N, Hashmi S . Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease. EBioMedicine. 2019; 47:446-456. PMC: 6796530. DOI: 10.1016/j.ebiom.2019.08.069. View

19.

Blackburn E . Structure and function of telomeres. Nature. 1991; 350(6319):569-73. DOI: 10.1038/350569a0. View

20.

Hollerer I, Barker J, Jorgensen V, Tresenrider A, Dugast-Darzacq C, Chan L . Evidence for an Integrated Gene Repression Mechanism Based on mRNA Isoform Toggling in Human Cells. G3 (Bethesda). 2019; 9(4):1045-1053. PMC: 6469420. DOI: 10.1534/g3.118.200802. View